When the FDA issues a warning, such as it did in June 2011 for the diabetes drug Actos, patients and their families often have lots of questions. In this post, we’ll answer three common questions about Actos and bladder cancer to provide you with some information that you can speak about with your doctor when discussing your diabetes treatment plan.
Question 1: When Did Actos Come on the Market? Actos came on the U.S. market in 1999. While other countries have taken Actos off the market for safety concerns, Actos remains on the market in the United States as of February 2012.
Question 2: Is Actos Safe? The FDA has warned patients and doctors that the use of Actos for more than one year, particularly in patients who have had or currently have bladder cancer, may be dangerous. Specifically, the prolonged use of Actos for these patients may increase the risk of developing bladder cancer.
Question 3: Does Actos cause cancer? While the FDA has not yet determined that Actos causes cancer, it has unequivocally said that Actos can raise the risk of developing bladder cancer for some patients.
We hope this information is useful to you as you and your doctor create a plan to manage your diabetes and other healthcare needs.